Scientist

Pharma in focus: rethinking GTM in a crowded market. 

The headache of go-to-market At &us, we have a long history of supporting clients in the pharma sector, and we’ve been doing some thinking alongside our partners, exploring interesting questions and making observations about the market and its shifting context.  One thing we can’t escape is that the sector is at an interesting stage of market maturity.  What do we …

A billion reasons to make progress

We frequently handle complex product development projects, and see clients stuck all the time – in constant ideation, in analysis paralysis, in struggling to get started, knowing how to move forwards. Except that this was an ethics, compliance and risk management product, and there was a very real and urgent reason to make real and rapid progress. Our client is …